cyfluthrin has been researched along with Community Acquired Infection in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chahine, EB; El-Lababidi, RM; Karaoui, LR; Mansour, H | 1 |
Cannons, AC; Cattani, J; Eiznhamer, DA; Luna, VA; Xu, ZQ | 1 |
Eiznhamer, DA; English, ML; Flavin, MT; Fredericks, CE; Jenta, TR; Milanesio, NA; Rohowsky, N; Xu, ZQ | 1 |
Hammerschlag, MR; Sharma, R | 1 |
Casellas, JM; Gliosca, L; Tomé, G; Visser, M | 1 |
Fluit, AC; Milatovic, D; Schmitz, FJ; Schwarz, S; Verhoef, J | 1 |
2 review(s) available for cyfluthrin and Community Acquired Infection
Article | Year |
---|---|
Cethromycin: a new ketolide antibiotic.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Community-Acquired Infections; Drug Interactions; Drug Resistance, Bacterial; Humans; Ketolides; Microbial Sensitivity Tests | 2013 |
Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections.
Topics: Animals; Anti-Bacterial Agents; Clinical Trials as Topic; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Microbial Sensitivity Tests; Molecular Structure; Respiratory Tract Infections; Treatment Outcome | 2008 |
1 trial(s) available for cyfluthrin and Community Acquired Infection
Article | Year |
---|---|
Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Endpoint Determination; Ethnicity; Female; Humans; Ketolides; Male; Middle Aged; Pneumonia; Sex Factors; Treatment Outcome; Young Adult | 2012 |
3 other study(ies) available for cyfluthrin and Community Acquired Infection
Article | Year |
---|---|
Susceptibility of 170 isolates of the USA300 clone of MRSA to macrolides, clindamycin and the novel ketolide cethromycin.
Topics: Anti-Bacterial Agents; Clindamycin; Community-Acquired Infections; Cross Infection; Humans; Ketolides; Macrolides; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 2008 |
In vitro activity of the new ketolide ABT-773 against community acquired respiratory tract isolates and Viridans Streptococci.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2002 |
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Haemophilus influenzae; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Streptococcus | 2002 |